Article Versions Notes

Slootbeek PHJ, Kloots ISH, van Oort IM, Kroeze LI, Schalken JA, Bloemendal HJ, Mehra N. Cross-Resistance between Platinum-Based Chemotherapy and PARP Inhibitors in Castration-Resistant Prostate Cancer. Cancers. 2023; 15(10):2814. https://doi.org/10.3390/cancers15102814

Slootbeek, Peter H. J., Iris S. H. Kloots, Inge M. van Oort, Leonie I. Kroeze, Jack A. Schalken, Haiko J. Bloemendal, and Niven Mehra. 2023. "Cross-Resistance between Platinum-Based Chemotherapy and PARP Inhibitors in Castration-Resistant Prostate Cancer" Cancers 15, no. 10: 2814. https://doi.org/10.3390/cancers15102814

Slootbeek, P. H. J., Kloots, I. S. H., van Oort, I. M., Kroeze, L. I., Schalken, J. A., Bloemendal, H. J., & Mehra, N. (2023). Cross-Resistance between Platinum-Based Chemotherapy and PARP Inhibitors in Castration-Resistant Prostate Cancer. Cancers, 15(10), 2814. https://doi.org/10.3390/cancers15102814